| Literature DB >> 19816442 |
Abstract
Dozens of companies are trying to leverage social networking and other software tools to accelerate trials and reduce their cost.Mesh:
Year: 2009 PMID: 19816442 DOI: 10.1038/nbt1009-895
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908